On the other board a reliable poster indicated that the company anticipated the end of the Phase 1 safety trial and collection of data and that investors would be informed when it occurs. I questioned why that couldn't have been stated in the recent quarterly, but I believe it is at least an indication that the trial is fully subscribed and close to reaching the full duration of time for the last of the people who entered the trial.
While I believe the company could tell us far more than the do, I also must admit that other companies have often been as bad.
No telling what discussions may be going on under confidentiality agreements, but the only ones we'll ever know about are those that come to fruition.
Gary
(0)
(0)
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links